151 related articles for article (PubMed ID: 37081671)
1. Establishment of a novel experimental system using single cell-derived pleomorphic rhabdomyosarcoma cell lines expressing K-RasG12V and deficient in p53.
Saito H; Suzuki N
Exp Anim; 2023 Nov; 72(4):446-453. PubMed ID: 37081671
[TBL] [Abstract][Full Text] [Related]
2. Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice.
Tsumura H; Yoshida T; Saito H; Imanaka-Yoshida K; Suzuki N
Oncogene; 2006 Dec; 25(59):7673-9. PubMed ID: 16785989
[TBL] [Abstract][Full Text] [Related]
3. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers.
Furlong MA; Mentzel T; Fanburg-Smith JC
Mod Pathol; 2001 Jun; 14(6):595-603. PubMed ID: 11406662
[TBL] [Abstract][Full Text] [Related]
4. Genomic profiling of pleomorphic rhabdomyosarcoma reveals a genomic signature distinct from that of embryonal rhabdomyosarcoma.
Saoud C; Dermawan JK; Sharma AE; Tap W; Wexler LH; Antonescu CR
Genes Chromosomes Cancer; 2024 May; 63(5):e23238. PubMed ID: 38722224
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathologic features of pleomorphic rhabdomyosarcoma].
Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):147-52. PubMed ID: 23769431
[TBL] [Abstract][Full Text] [Related]
6. p53 mutation and loss have different effects on tumourigenesis in a novel mouse model of pleomorphic rhabdomyosarcoma.
Doyle B; Morton JP; Delaney DW; Ridgway RA; Wilkins JA; Sansom OJ
J Pathol; 2010 Oct; 222(2):129-37. PubMed ID: 20662002
[TBL] [Abstract][Full Text] [Related]
7. Complete loss of
Beird HC; Wu CC; Nakazawa M; Ingram D; Daniele JR; Lazcano R; Little L; Davies C; Daw NC; Wani K; Wang WL; Song X; Gumbs C; Zhang J; Rubin B; Conley A; Flanagan AM; Lazar AJ; Futreal PA
HGG Adv; 2023 Oct; 4(4):100224. PubMed ID: 37593416
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of a bladder pleomorphic rhabdomyosarcoma in an adult patient.
Feroce F; Cantile M; Aquino G; Collina F; Scognamiglio G; Castaldo L; Perdonà S; Botti G; De Chiara A
Pathol Res Pract; 2020 Aug; 216(8):153033. PubMed ID: 32703497
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic and real-time quantitative reverse-transcriptase polymerase chain reaction analyses in pleomorphic rhabdomyosarcoma.
Li G; Ogose A; Kawashima H; Umezu H; Hotta T; Tohyama T; Ariizumi T; Endo N
Cancer Genet Cytogenet; 2009 Jul; 192(1):1-9. PubMed ID: 19480930
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice.
Ianzano ML; Croci S; Nicoletti G; Palladini A; Landuzzi L; Grosso V; Ranieri D; Dall'Ora M; Santeramo I; Urbini M; De Giovanni C; Lollini PL; Nanni P
Oncotarget; 2014 Jan; 5(1):108-19. PubMed ID: 24334679
[TBL] [Abstract][Full Text] [Related]
11. Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cells.
Blum JM; Añó L; Li Z; Van Mater D; Bennett BD; Sachdeva M; Lagutina I; Zhang M; Mito JK; Dodd LG; Cardona DM; Dodd RD; Williams N; Ma Y; Lepper C; Linardic CM; Mukherjee S; Grosveld GC; Fan CM; Kirsch DG
Cell Rep; 2013 Nov; 5(4):933-40. PubMed ID: 24239359
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of 10 pleomorphic rhabdomyosarcomas reveals potential prognostic markers and druggable targets.
Chelsky ZL; Paulson VA; Chen EY
Genes Chromosomes Cancer; 2022 Mar; 61(3):138-147. PubMed ID: 34773670
[TBL] [Abstract][Full Text] [Related]
13. Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma.
Slemmons KK; Crose LE; Rudzinski E; Bentley RC; Linardic CM
PLoS One; 2015; 10(10):e0140781. PubMed ID: 26496700
[TBL] [Abstract][Full Text] [Related]
14. K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applications.
Nakahata K; Simons BW; Pozzo E; Shuck R; Kurenbekova L; Prudowsky Z; Dholakia K; Coarfa C; Patel TD; Donehower LA; Yustein JT
Dis Model Mech; 2022 Feb; 15(2):. PubMed ID: 35174853
[TBL] [Abstract][Full Text] [Related]
15. Establishment and Characterization of a Sclerosing Spindle Cell Rhabdomyosarcoma Cell Line with a Complex Genomic Profile.
Schleicher S; Grote S; Malenke E; Chan KC; Schaller M; Fehrenbacher B; Riester R; Kluba T; Frauenfeld L; Boesmueller H; Göhring G; Schlegelberger B; Handgretinger R; Kopp HG; Traub F; Boehme KA
Cells; 2020 Dec; 9(12):. PubMed ID: 33322555
[TBL] [Abstract][Full Text] [Related]
16. Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice.
Nanni P; Nicoletti G; De Giovanni C; Croci S; Astolfi A; Landuzzi L; Di Carlo E; Iezzi M; Musiani P; Lollini PL
Cancer Res; 2003 Jun; 63(11):2728-32. PubMed ID: 12782574
[TBL] [Abstract][Full Text] [Related]
17. P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines.
Taylor AC; Shu L; Danks MK; Poquette CA; Shetty S; Thayer MJ; Houghton PJ; Harris LC
Med Pediatr Oncol; 2000 Aug; 35(2):96-103. PubMed ID: 10918230
[TBL] [Abstract][Full Text] [Related]
18. p53 family members in myogenic differentiation and rhabdomyosarcoma development.
Cam H; Griesmann H; Beitzinger M; Hofmann L; Beinoraviciute-Kellner R; Sauer M; Hüttinger-Kirchhof N; Oswald C; Friedl P; Gattenlöhner S; Burek C; Rosenwald A; Stiewe T
Cancer Cell; 2006 Oct; 10(4):281-93. PubMed ID: 17045206
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of solid tumor growth by Fas ligand-expressing myoblasts.
Springer ML; Kraft PE; Blau HM
Somat Cell Mol Genet; 1998 Sep; 24(5):281-9. PubMed ID: 10696236
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal imbalances in pleomorphic rhabdomyosarcomas and identification of the alveolar rhabdomyosarcoma-associated PAX3-FOXO1A fusion gene in one case.
Gordon A; McManus A; Anderson J; Fisher C; Abe S; Nojima T; Pritchard-Jones K; Shipley J
Cancer Genet Cytogenet; 2003 Jan; 140(1):73-7. PubMed ID: 12550764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
